• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background: In 2007, the American Heart Association published updated evidence-based
guidelines on the recommended use of antibiotic prophylaxis to prevent viridans group …

Infective endocarditis is defined by a focus of infection within the heart and is a feared
disease across the field of cardiology. It is frequently acquired in the health care setting, and …

JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis Toggle navigation
J-STAGE home Browse All titles All subject areas All publishers Search articles Search …

Aim To provide a contemporary analysis of incidence trends of infective endocarditis (IE)
with its changing epidemiology over the past two decades in Europe. Methods A systematic …

Objective The use of antibiotic prophylaxis (AP) for prevention of infective endocarditis (IE) is
controversial. In recent years, guidelines to cardiologists and dentists have advised …

Objectives To analyse the effectiveness of dalbavancin (DBV) in clinical practice as
consolidation therapy in patients with bloodstream infection (BSI) and/or infective …

Abstract Background: The American Heart Association updated its recommendations for
antibiotic prophylaxis (AP) to prevent infective endocarditis (IE) in 2007, advising that AP …

Dalbavancin is a parenteral lipoglycopeptide antibiotic derived from teicoplanin, an
analogue of vancomycin. It is mainly used for skin and soft tissue infections. The sustained …

Abstract Purpose of Review Additional imaging modalities, such as FDG-PET/CT, have been
included into the workup for patients with suspected infective endocarditis, according to …